New Organs Biotech

Pioneering xenotransplantation, alleviating the global organ shortage crisis

Explore the pressing issue of organ scarcity worldwide, where the demand far exceeds the available supply. Discover the challenges faced by patients in critical need and the alarming statistics that underscore the urgency of finding innovative solutions.

The Organ Shortage Crisis: A Global Challenge

Throughout the world, there is a constant increase in the number of patients who, due to various patholo-gies, have a critical need for organ transplants.

However, the number of organs available, whether from living or deceased donors, is very limited. This generates long waiting lists, which continue to grow each year. In 2021, according to the WHO, only 10% of the organ demand was covered, leaving more than 1M people waiting around the world.

Even though in many countries there have been changes in the legislation in favor of organ donation, the gap between organ supply and demand continues to widen and the problem remains unsolved.

cerdos5

Xenotransplantation: Bridging the Gap in Organ Transplants

Transplantation of animal organs, such as pigs to humans, known as xenotransplantation, is the most feasible alternative to respond to this growing unmet demand for organs. But the incompatibility generates hyperacute immune rejection.

New Organs Biotech can produce human compatible pigs. These pigs must carry certain modifications in their genome to avoid immune rejection in human patients and to increase human compatibility.

The latest gene editing technologies, as well as the knowledge of pig and human genomes, will allow New Organs Biotech to achieve this goal.

micromanipulacion (3)

Xenotransplantation Market: Shaping the Future of Transplants

Delve into the projected growth of the global transplantation market and the pivotal role of xenotransplantation in meeting the rising demand for organs. Explore the market dynamics, trends, and New Organs Biotech's contribution to shaping the future of organ transplants.

The global transplantation market is projected to grow from $14.37 billion in 2022 to $27.18 billion by 2029, at a CAGR of 9.5% in forecast period, 2022-2029.

In addition, tissue product segment wasthe highest revenue contributor in the global transplantation market in 2022, accounting for a market value share of nearly 59%.

Unveiling Scientific Prowess

Welcome to the innovative core of New Organs, where scientific excellence breathes life into our commitment to xenotransplantation.
Meet the brilliant minds leading the revolution in organ science:

jero2

Jerónimo Diosque

CEO
1517453782906

Laura Ratner

CSO
qNy7rtdRB_720x0__1

Rafael F. Martin

CIO
1590120400567

Gastón Emilio La Motta

CRO